GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:19735445

From GONUTS
Jump to: navigation, search
Citation

Minelli, A, Conte, C, Grottelli, S, Bellezza, I, Emiliani, C and Bolaños, JP (2009) Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signalling. J. Neurochem. 111:956-66

Abstract

Paraquat (1,1'-dimethyl-4,4'-bipyridinium), a widely used non-selective herbicide, is a redox cycling agent with adverse effects on dopamine systems. Epidemiological data have shown that exposure to paraquat is one of the several risk factors for Parkinson's disease. We have already shown that cyclo(His-Pro), an endogenous cyclic dipeptide produced by the cleavage of the thyrotropin releasing hormone, has a cytoprotective effect through a mechanism involving Nrf2 activation that decreases production of reactive oxygen species and increases glutathione synthesis. Using primary neuronal cultures and PC12 cells as targets of paraquat neurotoxicity, we addressed whether and how cyclo(His-Pro) causes cellular protective response against paraquat-mediated cell death. We found that cyclo(His-Pro) attenuated reactive oxygen species production, and prevented glutathione depletion by up-regulating Nrf2 gene expression, triggering its nuclear accumulation and activating the expression of heme oxygenase1. These protective effects were abolished by RNA interference-mediated Nrf2 knock down whereas were unaffected by RNA interference-mediated Keap1 knock down. Inhibition of heme oxygenase activity decreased cyclo(His-Pro)-induced neuroprotection. These results suggest that cyclo(His-Pro), acting as a selective activator of the brain modulable Nrf2 pathway, may be a promising candidate as neuroprotective agent that act through induction of phase II genes.

Links

PubMed Online version:10.1111/j.1471-4159.2009.06376.x

Keywords

Animals; Antioxidants/pharmacology; Brain/cytology; Cells, Cultured; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay/methods; Embryo, Mammalian; Enzyme Activation/drug effects; Enzyme Inhibitors/pharmacology; Female; Heme Oxygenase-1/genetics; Heme Oxygenase-1/metabolism; Herbicides/pharmacology; Intracellular Signaling Peptides and Proteins; NF-E2-Related Factor 2/genetics; NF-E2-Related Factor 2/metabolism; Neurons/drug effects; Paraquat/pharmacology; Peptides, Cyclic/pharmacology; Peroxiredoxins/metabolism; Piperazines/pharmacology; Pregnancy; Proteins/genetics; Proteins/metabolism; RNA, Messenger/metabolism; RNA, Small Interfering/metabolism; RNA, Small Interfering/pharmacology; Rats; Rats, Wistar; Signal Transduction/drug effects; Signal Transduction/physiology; Time Factors; Transfection/methods; Up-Regulation/drug effects

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:NF2L2

enables

GO:0043565: sequence-specific DNA binding

ECO:0000314: direct assay evidence used in manual assertion

F

Seeded From UniProt

complete

RAT:NF2L2

involved_in

GO:0060548: negative regulation of cell death

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete

Notes

See also

References

See Help:References for how to manage references in GONUTS.